Role of catalytic and non-catalytic subsite residues in ribonuclease activity of human eosinophil-derived neurotoxin

Biological Chemistry

Volumn 390, Issue 3, 2009, Pages 225-234

  Sikriwal, Deepa ^a   Seth, Divya ^a   Batra, Janendra K ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Catalysis; Eosinophil cationic protein (ECP); Eosinophil derived neurotoxin (EDN); Ribonuclease; RNA; RNase A; Subsite

Indexed keywords

EOSINOPHIL PROTEIN X; PHOSPHATE; POLYURIDYLIC ACID; RIBONUCLEASE; RIBONUCLEASE A; RNA;

ARTICLE; BINDING SITE; CATALYSIS; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; EOSINOPHIL; HUMAN; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN RNA BINDING;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; CIRCULAR DICHROISM; EOSINOPHIL-DERIVED NEUROTOXIN; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; RIBONUCLEASES; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, FLUORESCENCE;

EID: 62249085454     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.025     Document Type: Article

References (36)

1. Beintema, J.J. (1989). Presence of a basic amino acid residue at either position 66 or 122 is a condition for enzymic activity in the ribonuclease superfamily. FEBS Lett. 254, 1-4.
2. Beintema, J.J., Schuller, C., Irie, M., and Carsana, A. (1988). Molecular evolution of the ribonuclease superfamily. Prog. Biophys. Mol. Biol. 51, 165-192.
3. Blank, A., Sugiyama, R.H., and Dekker, C.A. (1982). Activity staining of nucleolytic enzymes after sodium dodecyl sulfate-polyacrylamide gel electrophoresis: use of aqueous isopropanol to remove detergent from gels. Anal. Biochem. 120, 267-275.
4. Boix, E., Nogues, M.V., Schein, C.H., Benner, S.A., and Cuchillo, C.M. (1994). Reverse transphosphorylation by ribonuclease A needs an intact p2-binding site. Point mutations at Lys-7 and Arg-10 alter the catalytic properties of the enzyme. J. Biol. Chem. 269, 2529-2534.
5. Boix, E., Nikolovski, Z., Moiseyev, G.P., Rosenberg, H.F., Cuchillo, C.M., and Nogues, M.V. (1999). Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonucleasetype activity. J. Biol. Chem. 274, 15605-15614.
6. Bond, M.D. (1988). An in vitro binding assay for angiogenin using placental ribonuclease inhibitor. Anal. Biochem. 173, 166-173.
7. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
8. Buchner, J., Pastan, I., and Brinkmann, U. (1992). A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205, 263-270.
9. D'Alessio, G. (1993). New and cryptic biological messages from RNases. Trends Cell Biol. 3, 106-109.
10. Domachowske, J.B., Dyer, K.D., Bonville, C.A., and Rosenberg, H.F. (1998). Recombinant human eosinophil-derived neurotoxin/ RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J. Infect. Dis. 177, 1458-1464.
11. Durack, D.T., Ackerman, S.J., Loegering, D.A., and Gleich, G.J. (1981). Purification of human eosinophil-derived neurotoxin. Proc. Natl. Acad. Sci. USA 78, 5165-5169.
12. Dyer, K.D. and Rosenberg, H.F. (2006). The RNase a superfamily: generation of diversity and innate host defense. Mol. Divers. 10, 585-597.
13. Fisher, B.M., Grilley, J.E., and Raines, R.T. (1998). A new remote subsite in ribonuclease A. J. Biol. Chem. 273, 34134-34138.
14. Fontecilla-Camps, J.C., de Llorens, R., le Du, M.H., and Cuchillo, C.M. (1994). Crystal structure of ribonuclease A.d-(ApTpApApG) complex. Direct evidence for extended substrate recognition. J. Biol. Chem. 269, 21526-21531.
15. Fredens, K., Dahl, R., and Venge, P. (1982). The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J. Allergy Clin. Immunol. 70, 361-366.
16. Gleich, G.J. and Adolphson, C.R. (1986). The eosinophilic leukocyte: structure and function. Adv. Immunol. 39, 177-253.
17. Gullberg, U., Widegren, B., Arnason, U., Egesten, A., and Olsson, I. (1986). The cytotoxic eosinophil cationic protein (ECP) has ribonuclease activity. Biochem. Biophys. Res. Commun. 139, 1239-1242.
18. Harper, J.W., Auld, D.S., Riordan, J.F., and Vallee, B.L. (1988). Enzymatically active angiogenin/ribonuclease A hybrids formed by peptide interchange. Biochemistry 27, 219-226.
19. Kunkel, T.A., Roberts, J.D., and Zakour, R.A. (1987). Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154, 367-382.
20. Laccetti, P., Portella, G., Mastronicola, M.R., Russo, A., Piccoli, R., D'Alessio, G., and Vecchio, G. (1992). In vivo and in vitro growth-inhibitory effect of bovine seminal ribonuclease on a system of rat thyroid epithelial transformed cells and tumors. Cancer Res. 52, 4582-4586.
21. Lehrer, R.I., Szklarek, D., Barton, A., Ganz, T., Hamann, K.J., and Gleich, G.J. (1989). Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J. Immunol. 142, 4428-4434.
22. Leonidas, D.D., Boix, E., Prill, R., Suzuki, M., Turton, R., Minson, K., Swaminathan, G.J., Youle, R.J., and Acharya, K.R. (2001). Mapping the ribonucleolytic active site of eosinophil-derived neurotoxin (EDN). High resolution crystal structures of EDN complexes with adenylic nucleotide inhibitors. J. Biol. Chem. 276, 15009-15017.
23. Mallorqui-Fernandez, G., Pous, J., Peracaula, R., Aymami, J., Maeda, T., Tada, H., Yamada, H., Seno, M., de Llorens, R., Gomis-Ruth, F.X., et al. (2000). Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 Å resolution. J. Mol. Biol. 300, 1297-1307.
24. McPherson, A., Brayer, G., Cascio, D., and Williams, R. (1986). The mechanism of binding of a polynucleotide chain to pancreatic ribonuclease. Science 232, 765-768.
25. Mosimann, S.C., Newton, D.L., Youle, R.J., and James, M.N. (1996). X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin at 1.83 Å resolution. J. Mol. Biol. 260, 540-552.
26. Nitta, K., Ozaki, K., Ishikawa, M., Furusawa, S., Hosono, M., Kawauchi, H., Sasaki, K., Takayanagi, Y., Tsuiki, S., and Hakomori, S. (1994). Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily. Cancer Res. 54, 920-927.
27. Raines, R.T. (1998). Ribonuclease A. Chem. Rev. 98, 1045-1066.
28. Richardson, R.M., Pares, X., and Cuchillo, C.M. (1990). Chemical modification by pyridoxal 5′-phosphate and cyclohexane-1,2-dione indicates that Lys-7 and Arg-10 are involved in the p2 phosphate-binding subsite of bovine pancreatic ribonuclease A. Biochem. J. 267, 593-599.
29. Rosenberg, H.F., Tenen, D.G., and Ackerman, S.J. (1989). Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc. Natl. Acad. Sci. USA 86, 4460-4464.
30. Rugeles, M.T., Trubey, C.M., Bedoya, V.I., Pinto, L.A., Oppenheim, J.J., Rybak, S.M., and Shearer, G.M. (2003). Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. AIDS 17, 481-486.
31. Sanger, F., Nicklen, S., and Coulson, A.R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
32. Sikriwal, D., Seth, D., Dey, P., and Batra, J.K. (2007). Human eosinophil-derived neurotoxin: involvement of a putative noncatalytic phosphate-binding subsite in its catalysis. Mol. Cell. Biochem. 303, 175-181.
33. Slifman, N.R., Loegering, D.A., McKean, D.J., and Gleich, G.J. (1986). Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J. Immunol. 137, 2913-2917.
34. Sorrentino, S., Glitz, D.G., Hamann, K.J., Loegering, D.A., Checkel, J.L., and Gleich, G.J. (1992). Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity. J. Biol. Chem. 267, 14859-14865.
35. Swaminathan, G.J., Holloway, D.E., Veluraja, K., and Acharya, K.R. (2002). Atomic resolution (0.98 Å ) structure of eosinophil-derived neurotoxin. Biochemistry 41, 3341-3352.
36. Tanimizu, N., Ueno, H., and Hayashi, R. (1998). Role of Phe120 in the activity and structure of bovine pancreatic ribonuclease A. J. Biochem. 124, 410-416.